The original report comparing CIC-DUX4 and EWSR1-NFATc2 positive tumors identified key molecular markers differentiating the two diseases; presenting PAX7 as a highly specific marker for EWSR1-NFATc2 positive tumor diagnosis. The gene discussed is DUX4; the disease is neoplasm.